tranexamic acid

Generic: tranexamic acid

Labeler: nordic pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name tranexamic acid
Generic Name tranexamic acid
Labeler nordic pharma, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tranexamic acid 650 mg/1

Manufacturer
Nordic Pharma, Inc.

Identifiers & Regulatory

Product NDC 69918-301
Product ID 69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA022430
Listing Expiration 2026-12-31
Marketing Start 2016-03-01

Pharmacologic Class

Established (EPC)
antifibrinolytic agent [epc]
Physiologic Effect
decreased fibrinolysis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69918301
Hyphenated Format 69918-301

Supplemental Identifiers

RxCUI
883826
UNII
6T84R30KC1
NUI
N0000175634 N0000175632

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tranexamic acid (source: ndc)
Generic Name tranexamic acid (source: ndc)
Application Number NDA022430 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 650 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (69918-301-30)
source: ndc

Packages (1)

69918-301-30 30 TABLET in 1 BOTTLE (69918-301-30)

Ingredients (1)

tranexamic acid (650 mg/1)

Linked Drug Pages (1)

Tranexamic Acid ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7bafece1-f0b8-4852-92ca-fe2bf261be04", "openfda": {"nui": ["N0000175634", "N0000175632"], "unii": ["6T84R30KC1"], "rxcui": ["883826"], "spl_set_id": ["031bf7c2-3b07-469d-bc5a-31fc6238e25f"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Nordic Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69918-301-30)", "package_ndc": "69918-301-30", "marketing_start_date": "20160301"}], "brand_name": "Tranexamic Acid", "product_id": "69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04", "dosage_form": "TABLET", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "69918-301", "generic_name": "Tranexamic Acid", "labeler_name": "Nordic Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tranexamic Acid", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "650 mg/1"}], "application_number": "NDA022430", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20160301", "listing_expiration_date": "20261231"}